Lack of a consistent relationship between demethylation of the CD44 promoter and CD44 expression

被引:0
|
作者
Robert Hyman
机构
[1] Molecular and Cell Biology Laboratory,
[2] Salk Institute,undefined
[3] Box 85800,undefined
[4] San Diego,undefined
[5] CA 92186-5800,undefined
[6] USA,undefined
来源
Immunogenetics | 2002年 / 53卷
关键词
CD44 Methylation Promoter Gene expression;
D O I
暂无
中图分类号
学科分类号
摘要
Methylation of the CD44 promoter at one or more CpG dinucleotides has been proposed as being important in the control of CD44 expression. In vitro methylation of all CpGs occurring between bases –1 to –1374 upstream of the position of translation initiation repressed the promoter activity of mouse CD44 4.5- to 12-fold in transient transfection experiments. Assaying the methylation of these 29 CpGs by genomic sequencing using differential base modification by sodium bisulfite indicated that a cluster of three CpGs immediately upstream of the position of translation initiation was heavily methylated in the mouse CD44-negative T-cell lymphoma AKR1. All 19 CpGs between bases –4 and –447, including the cluster heavily methylated in AKR1, were demethylated in the CD44-positive T-cell lymphoma BW5147, while CpGs further upstream showed no change in methylation pattern. The cluster of heavily methylated CpGs remained methylated, however, when CD44 was activated by transient transfection of c-jun into an AKR1 subline expressing polyoma large-T or by treatment of this subline with sodium butyrate, and no significant demethylation of other CpGs was observed. It is concluded, therefore, that no consistent demethylation event in the promoter-containing region encompassing the 1374 base pairs upstream of the position of CD44 translation initiation is required for CD44 expression.
引用
收藏
页码:914 / 924
页数:10
相关论文
共 50 条
  • [11] Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
    Cema, Ingrida
    Dzudzilo, Madara
    Kleina, Regina
    Franckevica, Ivanda
    Svirskis, Simons
    CANCERS, 2021, 13 (22)
  • [12] Relationship between CD44 expression and differentiation of human prostate adenocarcinomas
    Takahashi, S
    Kimoto, N
    Orita, S
    Cui, L
    Sakakibara, M
    Shirai, T
    CANCER LETTERS, 1998, 129 (01) : 97 - 102
  • [13] CD44 expression in astrocytic tumors
    Ylagan, L
    Quinn, B
    LABORATORY INVESTIGATION, 1997, 76 (01) : 890 - 890
  • [14] CD44 EXPRESSION ON MURINE TISSUES
    KENNEL, SJ
    LANKFORD, TK
    FOOTE, LJ
    SHINPOCK, SG
    STRINGER, C
    JOURNAL OF CELL SCIENCE, 1993, 104 : 373 - 382
  • [15] Expression of CD44 variants in osteosarcoma
    Kuryu, M
    Ozaki, T
    Nishida, K
    Shibahara, M
    Kawai, A
    Inoue, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (11) : 646 - 652
  • [16] CD44 expression in human gliomas
    Ranuncolo, SM
    Ladeda, V
    Specterman, S
    Varela, M
    Lastiri, J
    Morandi, A
    Matos, E
    Joffe, EBD
    Puricelli, L
    Pallotta, MG
    JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (01) : 30 - 35
  • [17] CD44 expression on epidermal melanocytes
    Herbold, KW
    Zhou, J
    Haggerty, JG
    Milstone, LM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (06) : 1230 - 1235
  • [18] CD44 expression in colorectal cancer
    Weg-Remers, S
    Schüder, G
    Zeitz, M
    Stallmach, A
    INTESTINAL PLASTICITY IN HEALTH AND DISEASE, 1998, 859 : 304 - 306
  • [19] CD44 expression in astrocytic tumors
    Ylagan, LR
    Quinn, B
    MODERN PATHOLOGY, 1997, 10 (12) : 1239 - 1246
  • [20] CD44 expression in tuberous sclerosis
    Arai, Y
    Takashima, S
    Becker, LE
    PATHOBIOLOGY, 2000, 68 (02) : 87 - 92